IGGA
EDIT icon

Iron Gate Global Advisors’s Editas Medicine EDIT Stock Holding History

Iron Gate Global Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-135
Closed -$5K – 252
2018
Q2 		$5K Buy
+135
New +$4.78K ﹤0.01% 167

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Iron Gate Global Advisors's EDIT Position: Q3 2018 in Review

Iron Gate Global Advisors sold out of Editas Medicine (EDIT) in Q3 2018, closing a stake of 135 shares — an estimated $5K sold.

Iron Gate Global Advisors first reported a position in EDIT in Q2 2018 and held it in 1 quarter. The position peaked at $5K in Q2 2018. 199 funds tracked by Wall St. Rank hold EDIT as of Q3 2018.

  • Iron Gate Global Advisors reported no remaining Editas Medicine position as of Q3 2018 after selling out during the quarter.
  • Iron Gate Global Advisors sold 135 Editas Medicine shares in Q3 2018, an estimated $5K.
  • Iron Gate Global Advisors first reported a position in Editas Medicine in Q2 2018 and held it in 1 quarter.
  • Iron Gate Global Advisors's Editas Medicine position peaked at $5K in Q2 2018.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2018.

Based on Iron Gate Global Advisors's 13F filing for Q3 2018, filed 16 Nov 2018.